trafermin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
fibroblast growth factors 5219 131094-16-1

Description:

MoleculeDescription

Synonyms:

  • trafermin
  • trafermin (genetical recombination)
  • fiblast
  • CAB-2001
  • KCB-1
used for treatment of stroke and coronary heart disease; RN amino acid sequence in first source
  • Molecular weight:
  • Formula:
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
April 4, 2001 PMDA Kaken

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC D03AX15 DERMATOLOGICALS
PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
CICATRIZANTS
Other cicatrizants
MeSH PA D002317 Cardiovascular Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Perforation of tympanic membrane indication 60442001
Alveolar bone loss indication 109706009




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
333OX80X87 UNII
C0757422 UMLSCUI
CHEMBL2108081 ChEMBL_ID
DB06244 DRUGBANK_ID
D03362 KEGG_DRUG
7367 INN_ID
DB14131 DRUGBANK_ID
C114444 MESH_SUPPLEMENTAL_RECORD_UI

Pharmaceutical products:

None